OR3-3 | In-Hospital Mortality of Patients Living with HIV Admitted Due to Cardiovascular Diseases according to their BMI: A Stratified Analysis of a Population-based Database

comorbidities, and medications.The primary outcome was 3-year allcause mortality, while secondary outcomes were 3-year incidence of instent restenosis (ISR) and revascularization (repeat PCI or coronary bypass surgery).Results: GLP-1 RA use was associated with a lower risk of all-cause mortality (HR 0.74, [0.596, 0.919]).There were no statistically significant differences in the secondary outcomes of ISR and revascularization.All outcome data is shown in Table 1.Conclusions: Our analysis suggests that GLP-1 RA use in patients with T2D after PCI for AMI is associated with reduced all-cause mortality.Further prospective, randomized studies are needed to confirm these findings.